Company: STGW
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000876883-25-000017
Chunk: 109

Company: Stagwell Inc
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 109
---
 1,880 77.7 %$36,574 $16,311 $20,263 124.2 %Operating Loss$(12,034)$(6,679)$(5,355)80.2 %

Three Months Ended March 31,20252024Change(dollars in thousands)$%Net Revenue$24,537 $9,632 $14,905 154.7 %Billable costs 3 — 3 100.0 %Revenue (1)24,540 9,632 14,908 154.8 %Billable costs3 — 3 100.0 %Staff costs15,455 7,821 7,634 97.6 %Administrative costs (1)8,225 3,209 5,016 156.3 %Unbillable and other costs, net7,187 2,588 4,599 177.7 %Adjusted EBITDA(6,330)(3,986)(2,344)58.8 %Stock-based compensation229 98 131 133.7 %Depreciation and amortization4,301 2,421 1,880 77.7 %Deferred acquisition consideration863 — 863 100.0 %Other items, net311 174 137 78.7 %Operating Loss$(12,034)$(6,679)$(5,355)80.2 %

(1) All Other Revenue and Administrative costs include approximately $5 million and $6 million of eliminations of intercompany services for the three months ended March 31, 2025, and 2024, respectively.

Revenue

Revenue for the three months ended March 31, 2025, was $24.5 million, compared to $9.6 million for the three months ended March 31, 2024, an increase of $14.9 million. 

44

Net Revenue

Net revenue for the three months ended March 31, 2025 was $24.5 million, compared to $9.6 million for the three months ended March 31, 2024, an increase of $14.9 million or 154.7%. The increase was primarily attributable to the acquisition of Unicepta.

Operating Loss

Operating Loss for the three months ended March 31, 2025, was $12.